Irfan Altafullah

Suggest Changes
Learn More
OBJECTIVE To perform a secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial, which tested the effect of treatment with atorvastatin in reducing(More)